Detalhe da pesquisa
1.
Design, Synthesis and Characterization of Covalent KDM5 Inhibitors.
Angew Chem Int Ed Engl
; 58(2): 515-519, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30431220
2.
Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
Cells
; 11(20)2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291153
3.
Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma.
Cancer Discov
; 12(2): 416-431, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551970
4.
Computation of the head-related transfer function via the fast multipole accelerated boundary element method and its spherical harmonic representation.
J Acoust Soc Am
; 127(1): 370-86, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20058984
5.
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
Eur J Med Chem
; 177: 316-337, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158747
6.
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.
J Med Chem
; 59(4): 1388-409, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26741168